DAA treatment for HCV reduce risk of hepatocellular carcinoma: a 10-years follow-up study based on Chinese patients with hepatitis C

Abstract The long-term benefits of direct-acting antiviral (DAA) therapy after achieving sustained virological response (SVR) remain uncertain in the Chinese population. This study evaluates the incidence of hepatocellular carcinoma (HCC), hepatic decompensation, and all-cause mortality among Chines...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Xiaobo Zhu, Linna Jia, Ming Yue, Amei Zhang, Xueshan Xia, Rongbin Yu, Hongbo Chen, Peng Huang
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-10-01
Subjects:	DAAs SVR HCC Hepatic decompensation All-cause mortality
Online Access:	https://doi.org/10.1038/s41598-024-75280-w